These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 37325493)

  • 1. Imaging Diagnosis of Various Hepatocellular Carcinoma Subtypes and Its Hypervascular Mimics: Differential Diagnosis Based on Conventional Interpretation and Artificial Intelligence.
    Minami Y; Nishida N; Kudo M
    Liver Cancer; 2023 Jun; 12(2):103-115. PubMed ID: 37325493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypervascular benign and malignant liver tumors that require differentiation from hepatocellular carcinoma: key points of imaging diagnosis.
    Murakami T; Tsurusaki M
    Liver Cancer; 2014 May; 3(2):85-96. PubMed ID: 24944999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypervascular liver lesions.
    Kamaya A; Maturen KE; Tye GA; Liu YI; Parti NN; Desser TS
    Semin Ultrasound CT MR; 2009 Oct; 30(5):387-407. PubMed ID: 19842564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can contrast enhanced ultrasound differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma?
    Huang JY; Li JW; Ling WW; Li T; Luo Y; Liu JB; Lu Q
    World J Gastroenterol; 2020 Jul; 26(27):3938-3951. PubMed ID: 32774068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging findings of mimickers of hepatocellular carcinoma.
    Kim TK; Lee E; Jang HJ
    Clin Mol Hepatol; 2015 Dec; 21(4):326-43. PubMed ID: 26770920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypervascular liver masses on contrast-enhanced ultrasound: the importance of washout.
    Bhayana D; Kim TK; Jang HJ; Burns PN; Wilson SR
    AJR Am J Roentgenol; 2010 Apr; 194(4):977-83. PubMed ID: 20308500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypervascular hepatic focal lesions: spectrum of imaging features.
    Namasivayam S; Salman K; Mittal PK; Martin D; Small WC
    Curr Probl Diagn Radiol; 2007; 36(3):107-23. PubMed ID: 17484954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease.
    Jang KM; Kim SH; Kim YK; Choi D
    Acta Radiol; 2015 May; 56(5):526-35. PubMed ID: 24838304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small hypervascular hepatocellular carcinomas: value of diffusion-weighted imaging compared with "washout" appearance on dynamic MRI.
    Kim DJ; Yu JS; Kim JH; Chung JJ; Kim KW
    Br J Radiol; 2012 Oct; 85(1018):e879-86. PubMed ID: 22573299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receiver operating characteristic analysis of diffusion-weighted magnetic resonance imaging in differentiating hepatic hemangioma from other hypervascular liver lesions.
    Vossen JA; Buijs M; Liapi E; Eng J; Bluemke DA; Kamel IR
    J Comput Assist Tomogr; 2008; 32(5):750-6. PubMed ID: 18830105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-Enhanced Ultrasound Patterns for the Non-invasive Diagnosis of Hepatocellular Carcinoma: A Prospective Multicenter Study in Histologically Proven Liver Lesions in a Real-Life Setting Demonstrating the Benefit of Extended Late Phase Observation.
    Schellhaas B; Bernatik T; Dirks K; Jesper D; Mauch M; Potthoff A; Zimmermann P; Strobel D
    Ultrasound Med Biol; 2021 Nov; 47(11):3170-3180. PubMed ID: 34417066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging Spectrum of Intrahepatic Mass-Forming Cholangiocarcinoma and Its Mimickers: How to Differentiate Them Using MRI.
    Kovač JD; Janković A; Đikić-Rom A; Grubor N; Antić A; Dugalić V
    Curr Oncol; 2022 Jan; 29(2):698-723. PubMed ID: 35200560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of volumetric contrast-enhanced and diffusion-weighted MRI in differentiating between common primary hypervascular liver tumors.
    Zarghampour M; Fouladi DF; Pandey A; Ghasabeh MA; Pandey P; Varzaneh FN; Khoshpouri P; Shao N; Pan L; Grimm R; Kamel IR
    J Magn Reson Imaging; 2018 Oct; 48(4):1080-1090. PubMed ID: 29630756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of gadoxetic acid-enhanced MRI and diffusion-weighted imaging in the differentiation of hypervascular hyperplastic nodule from small (<3 cm) hypervascular hepatocellular carcinoma in patients with alcoholic liver cirrhosis: A retrospective case-control study.
    Kim SS; Kim SH; Song KD; Choi SY; Heo NH
    J Magn Reson Imaging; 2020 Jan; 51(1):70-80. PubMed ID: 31062483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pearls and pitfalls in magnetic resonance imaging of hepatocellular carcinoma.
    Kovac JD; Milovanovic T; Dugalic V; Dumic I
    World J Gastroenterol; 2020 May; 26(17):2012-2029. PubMed ID: 32536771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging features of primary hepatic sarcomatoid carcinoma: Differentiation from hepatocellular carcinoma and intrahepatic cholangiocarcinoma on CT: A preliminary study.
    Chen L; Ruan S; Wang P; Cheng Y; Wang Y; Tian W; Zhang H; Zhang X; Liang W
    Heliyon; 2023 Mar; 9(3):e14123. PubMed ID: 36938423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fat in mass in primary liver lesions: are usual MRI diagnostic criteria of both malignant and benign liver lesions still applicable?
    Reizine E; Meurgey A; Amaddeo G; Laurent A; Calderaro J; Mule S; Luciani A
    Abdom Radiol (NY); 2022 Jul; 47(7):2347-2355. PubMed ID: 35672475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic hemangiomas: the various imaging avatars and its mimickers.
    Mathew RP; Sam M; Raubenheimer M; Patel V; Low G
    Radiol Med; 2020 Sep; 125(9):801-815. PubMed ID: 32249391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging.
    Yu JS; Lee JH; Chung JJ; Kim JH; Kim KW
    Acta Radiol; 2008 Sep; 49(7):735-43. PubMed ID: 18608015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.
    Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Muhi A; Araki T
    Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.